We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$7.46M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$6.58M -$6.32M -353,492 -39%
BlackRock
3
BlackRock
New York
$4.96M -$111K -6,213 -1%
AG
4
Artal Group
Luxembourg
$4.17M +$894K +50,000 +17%
ABG
5
Ally Bridge Group
New York
$4M -$313K -17,500 -5%
FP
6
Flagship Pioneering
Massachusetts
$3.5M
OFM
7
Omega Fund Management
Massachusetts
$2.99M
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.69M -$957K -53,484 -19%
SB
9
Samsara BioCapital
California
$2.26M -$518K -28,958 -13%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$2.26M
State Street
11
State Street
Massachusetts
$1.36M -$17.2K -959 -0.8%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.17M +$57.3K +3,203 +3%
SCM
13
Sio Capital Management
New York
$1.07M +$3.99K +223 +0.2%
Renaissance Technologies
14
Renaissance Technologies
New York
$975K +$1.46M +81,896 New
CS
15
Candriam SCA
Luxembourg
$695K
Millennium Management
16
Millennium Management
New York
$609K +$750K +41,952 +455%
LCP
17
LGT Capital Partners
Switzerland
$595K
Northern Trust
18
Northern Trust
Illinois
$579K -$67.6K -3,780 -7%
GCP
19
GSA Capital Partners
United Kingdom
$443K +$233K +13,008 +54%
Los Angeles Capital Management
20
Los Angeles Capital Management
California
$297K -$14.7K -822 -3%
Federated Hermes
21
Federated Hermes
Pennsylvania
$286K +$135K +7,532 +46%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$263K -$168K -9,413 -30%
Goldman Sachs
23
Goldman Sachs
New York
$257K -$498K -27,829 -56%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$227K -$6.67K -373 -2%
Two Sigma Investments
25
Two Sigma Investments
New York
$222K +$246K +13,770 +283%